Abstract
Novel diagnostic tools to measure retinal function and structure are rapidly being developed and introduced into clinical use. Opportunities exist to use these informative and robust measures as endpoints for clinical trials to determine efficacy and to monitor safety of therapeutic interventions. In order to inform researchers and clinician-scientists about these new diagnostic tools, a workshop was organized by the European Vision Institute. Invited speakers highlighted the recent advances in state-of-the-art technologies for outcome measures in the field of retina. This review highlights the workshop's presentations in the context of published literature.
| Original language | English (US) |
|---|---|
| Journal | Ophthalmic Research |
| DOIs | |
| State | Accepted/In press - Jan 1 2019 |
Fingerprint
Keywords
- Artificial intelligence
- Diagnostics
- Machine learning
- Retina
- Retinal disease
- Technologies
ASJC Scopus subject areas
- Ophthalmology
- Sensory Systems
- Cellular and Molecular Neuroscience
Cite this
New Technologies for Outcome Measures in Retinal Disease : Review from the European Vision Institute Special Interest Focus Group. / Della Volpe-Waizel, Maria; Traber, Ghislaine L.; Maloca, Peter; Zinkernagel, Martin; Schmidt-Erfurth, Ursula; Rubin, Gary; Roska, Botond; Otto, Tilman; Weleber, Richard; Scholl, Hendrik P.N.
In: Ophthalmic Research, 01.01.2019.Research output: Contribution to journal › Review article
}
TY - JOUR
T1 - New Technologies for Outcome Measures in Retinal Disease
T2 - Review from the European Vision Institute Special Interest Focus Group
AU - Della Volpe-Waizel, Maria
AU - Traber, Ghislaine L.
AU - Maloca, Peter
AU - Zinkernagel, Martin
AU - Schmidt-Erfurth, Ursula
AU - Rubin, Gary
AU - Roska, Botond
AU - Otto, Tilman
AU - Weleber, Richard
AU - Scholl, Hendrik P.N.
PY - 2019/1/1
Y1 - 2019/1/1
N2 - Novel diagnostic tools to measure retinal function and structure are rapidly being developed and introduced into clinical use. Opportunities exist to use these informative and robust measures as endpoints for clinical trials to determine efficacy and to monitor safety of therapeutic interventions. In order to inform researchers and clinician-scientists about these new diagnostic tools, a workshop was organized by the European Vision Institute. Invited speakers highlighted the recent advances in state-of-the-art technologies for outcome measures in the field of retina. This review highlights the workshop's presentations in the context of published literature.
AB - Novel diagnostic tools to measure retinal function and structure are rapidly being developed and introduced into clinical use. Opportunities exist to use these informative and robust measures as endpoints for clinical trials to determine efficacy and to monitor safety of therapeutic interventions. In order to inform researchers and clinician-scientists about these new diagnostic tools, a workshop was organized by the European Vision Institute. Invited speakers highlighted the recent advances in state-of-the-art technologies for outcome measures in the field of retina. This review highlights the workshop's presentations in the context of published literature.
KW - Artificial intelligence
KW - Diagnostics
KW - Machine learning
KW - Retina
KW - Retinal disease
KW - Technologies
UR - http://www.scopus.com/inward/record.url?scp=85070499078&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85070499078&partnerID=8YFLogxK
U2 - 10.1159/000501887
DO - 10.1159/000501887
M3 - Review article
AN - SCOPUS:85070499078
JO - Ophthalmic Research
JF - Ophthalmic Research
SN - 0030-3747
ER -